EA200101176A1 - Циклокарбаматные производные в качестве модуляторов рецептора прогестерона - Google Patents

Циклокарбаматные производные в качестве модуляторов рецептора прогестерона

Info

Publication number
EA200101176A1
EA200101176A1 EA200101176A EA200101176A EA200101176A1 EA 200101176 A1 EA200101176 A1 EA 200101176A1 EA 200101176 A EA200101176 A EA 200101176A EA 200101176 A EA200101176 A EA 200101176A EA 200101176 A1 EA200101176 A1 EA 200101176A1
Authority
EA
Eurasian Patent Office
Prior art keywords
substituted
alkyl
alkoxy
alkynyl
alkoalkyl
Prior art date
Application number
EA200101176A
Other languages
English (en)
Other versions
EA004512B1 (ru
Inventor
Пувен Жанг
Юджин А. Терефенко
Хорас Флетчер III
Эндрю Фенсам
Джей Э. Вроубел
Лин Жи
Тодд К. Джоунс
Кристофер М. Тегли
Джеймс П. Эдвардс
Original Assignee
Америкэн Хоум Продактс Корпорейшн
Лиганд Фармасьютикалз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/552,633 external-priority patent/US6509334B1/en
Application filed by Америкэн Хоум Продактс Корпорейшн, Лиганд Фармасьютикалз, Инк. filed Critical Америкэн Хоум Продактс Корпорейшн
Publication of EA200101176A1 publication Critical patent/EA200101176A1/ru
Publication of EA004512B1 publication Critical patent/EA004512B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/181,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Изобретение обеспечивает соединения формулы (1), где Rи Rпредставляют собой индивидуальные заместители или Rи Rсконденсированы с образованием спироциклического кольца, гетероциклического кольца, Rпредставляет собой Н, ОН, NH, C-Cалкил, замещенный C-Cалкил, C-Cалкенил, замещенный C-Cалкенил, алкинил или замещенный алкинил, или COR; Rвыбирают из Н, C-Cалкила, замещенного C-Cалкила, арила, замещенного арила, C-Cалкокси, замещенного C-Cалкокси, C-Cаминоалкила или замещенного C-Cаминоалкила; Rвыбирают из Н, галогена, CN, NO, C-Cалкила, замещенного C-Cалкила, алкинила или замещенного алкинила, C-Cалкокси, замещенного C-Cалкокси, амино, C-Cаминоалкила или замещенного C-Cаминоалкила; Rвыбирают из тризамещенного бензольного пяти- или шестичленного кольца с 1, 2 или 3 гетероатомами в кольце, выбранными из группы О, S, S(О), S(O) или NR, содержащее один или два независимых заместителя из группы Н, галогена, CN, NOи C-Cалкила, C-Cалкокси, C-Cаминоалкила, CORили NRCOR; или его фармацевтически приемлемые соли, а также фармацевтические композиции и способы применения соединений в качестве антагонистов рецептора прогестерона.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200101176A 1999-05-04 2000-05-01 Циклокарбаматные производные в качестве модуляторов рецептора прогестерона EA004512B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18301299P 1999-05-04 1999-05-04
US09/552,633 US6509334B1 (en) 1999-05-04 2000-04-19 Cyclocarbamate derivatives as progesterone receptor modulators
PCT/US2000/011822 WO2000066571A1 (en) 1999-05-04 2000-05-01 Cyclocarbamate derivatives as progesterone receptor modulators

Publications (2)

Publication Number Publication Date
EA200101176A1 true EA200101176A1 (ru) 2002-04-25
EA004512B1 EA004512B1 (ru) 2004-04-29

Family

ID=26878647

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200101176A EA004512B1 (ru) 1999-05-04 2000-05-01 Циклокарбаматные производные в качестве модуляторов рецептора прогестерона

Country Status (19)

Country Link
EP (1) EP1173426A1 (ru)
JP (1) JP2002543193A (ru)
KR (1) KR20010114250A (ru)
CN (1) CN1145618C (ru)
AU (1) AU766428B2 (ru)
BG (1) BG106079A (ru)
BR (1) BR0010213A (ru)
CA (1) CA2371726A1 (ru)
CZ (1) CZ20013951A3 (ru)
EA (1) EA004512B1 (ru)
HU (1) HUP0201609A3 (ru)
IL (1) IL146280A0 (ru)
MX (1) MXPA01011286A (ru)
NO (1) NO321361B1 (ru)
NZ (1) NZ515355A (ru)
PL (1) PL351127A1 (ru)
SG (1) SG114650A1 (ru)
SK (1) SK15912001A3 (ru)
TR (1) TR200103286T2 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1756095T3 (pl) * 2004-04-27 2008-10-31 Wyeth Corp Cyjanopirole zawierające cykliczne karbaminianowe i tiokarbaminianowe biaryle oraz sposoby ich wytwarzania
JPWO2006077821A1 (ja) * 2005-01-19 2008-06-19 大日本住友製薬株式会社 アルドステロン受容体調節剤としての芳香族スルホン化合物
CA2701406C (en) 2007-10-05 2016-01-26 Banyu Pharmaceutical Co., Ltd. Benzoxazinone derivative
CN111925353B (zh) * 2020-08-31 2022-04-08 苏州大学附属第二医院 一种2-噻吩甲腈的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0510235A1 (en) * 1991-04-26 1992-10-28 Dong-A Pharm. Co., Ltd. Novel benzoxazine or benzothiazine derivatives and process for the preparation of the same
WO1995020389A1 (en) * 1994-01-28 1995-08-03 Merck & Co., Inc. Benzoxazinones as inhibitors of hiv reverse transcriptase
EP1382597A3 (en) * 1994-12-22 2004-04-07 Ligand Pharmaceuticals, Inc. Steroid receptor modulator compounds and methods
EP0929533B1 (en) * 1996-10-02 2003-09-03 Bristol-Myers Squibb Pharma Company 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv reverse transcriptase inhibitors and intermediates and processes for making the same

Also Published As

Publication number Publication date
CN1145618C (zh) 2004-04-14
AU766428B2 (en) 2003-10-16
AU4688600A (en) 2000-11-17
NZ515355A (en) 2004-02-27
JP2002543193A (ja) 2002-12-17
MXPA01011286A (es) 2003-07-14
KR20010114250A (ko) 2001-12-31
CN1349517A (zh) 2002-05-15
EP1173426A1 (en) 2002-01-23
CA2371726A1 (en) 2000-11-09
TR200103286T2 (tr) 2002-07-22
NO20015378D0 (no) 2001-11-02
SG114650A1 (en) 2005-09-28
BG106079A (en) 2002-05-31
PL351127A1 (en) 2003-03-24
BR0010213A (pt) 2002-02-19
SK15912001A3 (sk) 2002-06-04
CZ20013951A3 (cs) 2002-05-15
IL146280A0 (en) 2002-07-25
NO321361B1 (no) 2006-05-02
HUP0201609A2 (en) 2002-08-28
NO20015378L (no) 2002-01-03
EA004512B1 (ru) 2004-04-29
HUP0201609A3 (en) 2002-12-28

Similar Documents

Publication Publication Date Title
UA72917C2 (en) Cyclic carbamates derivatives, pharmaceutical composition containing said derivatives of cyclic carbamates and active ingredients as modulators of the progesterone receptor
EA200600925A1 (ru) Производные триазола в качестве антагонистов вазопрессина
EA200100486A1 (ru) Производные 2-уреидотиазола, способ их получения и применение указанных веществ в качестве противоопухолевых средств
DE60140456D1 (de) Aza heterocyclische derivate und ihre therapeutische verwendung
PE20070212A1 (es) Heterociclos de 1,4-dihidropiridina-condensados, procesos para preparar los mismos, uso y composiciones que los contienen
WO2000066564A8 (en) Benzimidazolones and analogues and their use as progesterone receptor ligands
AR004219A1 (es) Nuevos derivados de quinazolina, procedimientos para su preparacion, composiciones que los contienen y su uso en la preparacion de medicamentos,particularmente en el tratamiento de trastornos inflamatorios
HUP0300565A2 (hu) PDE 5 inhibitor hatású 8-kinolin-xantin- és 8-izo-kinolin-xantin-származékok, alkalmazásuk, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
BR0110112A (pt) Derivados de pirrolidina e piperidina e seu uso para o tratamento de distúrbios neurodegenerativos
EA200300064A1 (ru) Карбоксамидные соединения и их применение в качестве антагонистов 11cby-рецептора человека
AR035153A1 (es) Derivados de carboxamidas y cetonas de dihidrobenzodioxina
EA200100902A1 (ru) Производные тетрагидропирана и их использование в качестве терапевтических агентов
HRP20090264T1 (en) Phenyl-piperazin methanone derivatives
EA200101181A1 (ru) Циклотиокарбаматные производные в качестве модуляторов рецептора прогестерона
DE60111464D1 (de) Azabicycloalkan-Derivate zur Verwendung als Inhibitoren der Serotonin-Wiederaufnahme und als 5HT2a Antagonisten
DK0902018T3 (da) 2-(arylpheny)amino-imidazolinderivater
EA200101176A1 (ru) Циклокарбаматные производные в качестве модуляторов рецептора прогестерона
CY1108837T1 (el) ΝΕΑ ΠΑΡΑΓΩΓΑ ΑΜΙΝΟΠΥΡΙΔΙΝΗΣ ΩΣ ΑΝΤΑΓΩΝΙΣΤΕΣ mGluR5
AR023111A1 (es) Derivados de sulfonamida utiles como antagonistas del receptor 5-ht7, un procedimiento para su preparacion y composicion farmaceutica que los comprenden
DE60013798D1 (de) Empfängnisverhütende zusammensetzungen die progestagen und progesteronantagonisten enthalten
BR0004548A (pt) Derivados i de quinolin-4-ila
AR027454A1 (es) Derivados de beta-alanina, utiles como antagonistas de receptores, las composiciones farmaceuticas que las contienen y el uso de los mismos para lapreparacion de medicamentos
EA200401077A1 (ru) 2-оксазоламины и их применение в качестве антагонистов рецептора 5-ht2b
DK0712406T3 (da) Kondenserende indolderivater som 5-HT4-receptorantagonister
AR029744A1 (es) Procedimiento para preparar tioamidas ciclicas y compuestos utiles en dicho procedimiento

Legal Events

Date Code Title Description
PD4A Registration of transfer of a eurasian patent in accordance with the succession in title
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU